Join to View Full Profile
101 Woodruff CirAtlanta, GA 30322
Dr. Hughes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Hughes is an endocrinologist based in Atlanta, GA, specializing in diabetes and lipid metabolism. He completed a fellowship in Endocrinology, Diabetes, and Metabolism at Stanford, after an internal medicine residency at Baylor College of Medicine. He graduated from McGovern Medical School at UTHealth in 2017. Currently, Dr. Hughes serves as an Assistant Professor at Emory University School of Medicine. Previously, he was an instructor and endocrinologist at Stanford. His expertise includes type I and II diabetes management, insulin pump therapy, and continuous glucose monitoring. Dr. Hughes has contributed to multiple publications on diabetes management and digital technology in diabetes care, with his work frequently cited by others. He is also involved in clinical trials concerning insulin delivery systems and has conducted research on various automated insulin delivery and monitoring technologies.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2020 - 2022
Baylor College of MedicineResidency, Internal Medicine, 2017 - 2020
McGovern Medical School at UTHealthClass of 2017
Certifications & Licensure
CA State Medical License 2020 - 2026
GA State Medical License 2024 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Omnipod 5 System Compared to Pump Therapy Start of enrollment: 2022 Jul 07
- Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes Start of enrollment: 2022 Aug 31
- Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility Start of enrollment: 2021 Jun 29
- Join now to see all
Publications & Presentations
PubMed
- Toward Automation: The Road Traveled and Road Ahead for Integrating Automated Insulin Delivery into Inpatient Care.Michael S Hughes, Francisco J Pasquel, Georgia M Davis, Rayhan A Lal, Bruce A Buckingham
Diabetes Technology & Therapeutics. 2025-03-01 - Diabetes Technology Use in Special Populations: A Narrative Review of Psychosocial Factors.Michael S Hughes, Grazia Aleppo, Lia Bally, Annanda Fernandes Moura B Batista, Sue A Brown
Journal of Diabetes Science and Technology. 2025-01-01 - 1 citationsDevelopment of a Real-time Force-based Algorithm for Infusion Failure Detection.Luis E Blanco, John H Wilcox, Michael S Hughes, Rayhan A Lal
Journal of Diabetes Science and Technology. 2024-11-01
Press Mentions
Personal CGM Use in Hospitals Feasible, Preferred by Nurses and PatientsAugust 26th, 2024- Continuous Glucose Monitoring Can Aid Hospital PatientsJune 23rd, 2024
Research History
- HHMI Medical Research Fellow2014 - 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
